Diabetes, Obesity, and Risk Prediction of Severe COVID-19

J Clin Endocrinol Metab. 2020 Oct 1;105(10):dgaa442. doi: 10.1210/clinem/dgaa442.

Authors

Ranganath Muniyappa¹, Kenneth J Wilkins²

Affiliations

¹ Clinical Endocrine Section, Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.
² Office of the Director, Biostatistics Program/Office of Clinical Research Support, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.

No abstract available

Publication types

Comment

MeSH terms

Betacoronavirus
COVID-19
Coronavirus Infections*
Diabetes Mellitus*
Humans
Mexico
Obesity
Pandemics*
Pneumonia, Viral*
SARS-CoV-2